PLATINUM-REFRACTORY OVARIAN CARCINOMA
Clinical trials for PLATINUM-REFRACTORY OVARIAN CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PLATINUM-REFRACTORY OVARIAN CARCINOMA trials appear
Sign up with your email to follow new studies for PLATINUM-REFRACTORY OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First patients to try groundbreaking oral cancer pill
Disease control Recruiting nowThis is the first study in people to test a new oral drug called NKT3964. It aims to see if the drug is safe and can help control advanced cancers that have spread and stopped responding to standard treatments. The study will enroll adults with specific advanced solid tumors, inc…
Matched conditions: PLATINUM-REFRACTORY OVARIAN CARCINOMA
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Modified virus attacks tough ovarian cancer in new trial
Disease control Recruiting nowThis early-stage trial is testing whether a specially engineered virus called TILT-123, when combined with existing cancer drugs, is safe and potentially effective for women with advanced ovarian cancer that has stopped responding to standard platinum chemotherapy. The virus is d…
Matched conditions: PLATINUM-REFRACTORY OVARIAN CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: TILT Biotherapeutics Ltd. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC